VALBIOTIS Stock Euronext Paris
Stocks
FR0013254851
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
||
| - PTS | - |
|
| 06-08 | Valbiotis Secures Exclusive Distributor in Qatar | MT |
| 06-08 | Valbiotis and Al Danah Medical Company Signs Exclusive Distribution Agreement for Valbiotispro Range in Qatar | CI |
| Market Cap | 20.44M 0 23.44M 18.93M 17.72M 33.24M 2.21B 33.44M 225M 87.04M 1.09B 88M 86.11M 3.78B | P/E 2026 * |
-2.29x | P/E 2027 * | -6.65x |
|---|---|---|---|---|---|
| Enterprise Value | 21.64M 0 24.82M 20.04M 18.76M 35.19M 2.34B 35.4M 238M 92.15M 1.15B 93.16M 91.17M 4B | EV / Sales 2026 * |
5.62x | EV / Sales 2027 * | 1.39x |
| Free-Float |
64% | Yield 2026 * |
-
| Yield 2027 * | - |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | - | |
Stanislas Sordet
DFI | Director of Finance/CFO | - | 2024-02-29 |
Pascal Sirvent
CTO | Chief Tech/Sci/R&D Officer | - | 2017-08-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Laurent Lévy
CHM | Chairman | 55 | 2017-02-28 |
Jean Zetlaoui
BRD | Director/Board Member | - | 2017-10-25 |
Agnès Tixier
BRD | Director/Board Member | - | 2019-03-17 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.44% | -1.25% | +64.25% | +114.23% | 55.19B | ||
| +4.60% | +3.02% | +57.38% | +48.98% | 45.75B | ||
| -1.44% | +0.39% | -14.68% | -17.33% | 22.98B | ||
| -2.69% | -2.10% | -6.70% | +374.02% | 20.76B | ||
| +3.22% | -0.84% | +27.88% | -20.46% | 16.26B | ||
| +0.58% | +1.08% | +18.85% | -37.32% | 15.42B | ||
| -1.01% | -2.30% | +28.59% | +174.08% | 13.05B | ||
| +4.95% | +11.70% | +125.78% | +252.19% | 12.45B | ||
| +3.07% | +0.14% | +29.05% | - | 12.37B | ||
| Average | +1.41% | +2.23% | +36.71% | +111.05% | 23.8B | |
| Weighted average by Cap. | +1.63% | +1.48% | +40.78% | +101.14% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.85M 0 4.42M 3.57M 3.34M 6.26M 417M 6.3M 42.3M 16.39M 205M 16.58M 16.22M 712M | 13.3M 0 15.25M 12.32M 11.53M 21.63M 1.44B 21.76M 146M 56.63M 708M 57.26M 56.03M 2.46B |
| Net income | -8.85M -0 -10.15M -8.2M -7.67M -14.39M -958M -14.48M -97.24M -37.68M -471M -38.1M -37.28M -1.64B | -5.4M -0 -6.19M -5M -4.68M -8.78M -584M -8.83M -59.33M -22.99M -288M -23.25M -22.75M -999M |
| Net Debt | 1.2M 0 1.38M 1.11M 1.04M 1.95M 130M 1.96M 13.18M 5.11M 63.92M 5.17M 5.06M 222M | -1.9M -0 -2.18M -1.76M -1.65M -3.09M -206M -3.11M -20.88M -8.09M -101M -8.18M -8M -351M |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Select your edition
All financial news and data tailored to specific country editions
















